TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22668797

Group type: EXPERIMENTAL
Intervention: Cilengitide 500 mg administered intravenously twice weekly
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Cilengitide 2000 mg administered intravenously twice weekly
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Overall treatment (both doses)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Overall αvβ3 expression
Number of subjects: 29
Study: 19323964

Group type: EXPERIMENTAL
Intervention: Relapse Prevention Therapy (RPT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standardized Case Management
Number of subjects: 81
Study: 17298495

Group type: EXPERIMENTAL
Intervention: Bone graft + Ti-Mesh
Number of subjects: 23

Group type: COMPARATOR
Intervention: Bone graft alone
Number of subjects: 23
Study: 15388612

Group type: EXPERIMENTAL
Intervention: Dogs trained to identify bladder cancer urine samples
Number of subjects: 144

Group type: COMPARATOR
Intervention: Expected value of chance selection (1 in 7 or 14%)
Number of subjects: 144
Study: 11172529

Group type: EXPERIMENTAL
Intervention: Stress-related pathways through medical illness
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biological, psychological, and psychosocial theories
Number of subjects: 0
Study: 9680665

Group type: EXPERIMENTAL
Intervention: Tetraphen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phenyl-Free
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both Tetraphen and Phenyl-Free
Number of subjects: 0
Study: 8004312

Group type: EXPERIMENTAL
Intervention: Airway Pressure Release Ventilation (APRV)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Volume-Controlled Inverse Ratio Ventilation (VC-IRV)
Number of subjects: 18
Study: 30350870

Group type: EXPERIMENTAL
Intervention: Custom-made toothbrush
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal toothbrush
Number of subjects: 30
Study: 27570090

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 3319

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 3319
Study: 24274627

Group type: EXPERIMENTAL
Intervention: supportive-expressive psychotherapy
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: clinical management combined with pharmacotherapy
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: clinical management combined with placebo
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: alliance
Number of subjects: 149

Group type: COMPARATOR
Intervention: No treatment differences
Number of subjects: 149
Study: 22644636

Group type: EXPERIMENTAL
Intervention: Early LH exposure (recombinant LH 150 IU/day from day 1)
Number of subjects: 530

Group type: COMPARATOR
Intervention: Late LH exposure (recombinant LH 150 IU/day from day 7)
Number of subjects: 530
Study: 20686612

Group type: EXPERIMENTAL
Intervention: Proprioceptive testing using a robotic linkage that passively moved the hand to each judgement location.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proprioceptive testing with a persistent visual reference position.
Number of subjects: 0
Study: 18693158

Group type: EXPERIMENTAL
Intervention: Topical methyl aminolaevulinate (MAL PDT)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 118
Study: 16725264

Group type: EXPERIMENTAL
Intervention: Glutamine granules (0.5 g/kg/d for 14 days)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Glutamine granules
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (placebo - glycine)
Number of subjects: 48
Study: 14609903

Group type: EXPERIMENTAL
Intervention: Sucrose and oral tactile stimulation (with a pacifier or a bottle) and parental holding during immunization
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standard practice (no sucrose or tactile stimulation)
Number of subjects: 116
Study: 11340889

Group type: EXPERIMENTAL
Intervention: Automated static threshold perimetry on Humphery visual field (HVF) analyzer
Number of subjects: 54

Group type: COMPARATOR
Intervention: Manual suprathreshold perimetry on Goldmann perimeter
Number of subjects: 54
Study: 8993082

Group type: EXPERIMENTAL
Intervention: Family-focused psychoeducational treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Individual, interpersonally-oriented psychotherapy
Number of subjects: 0
Study: 1511309

Group type: EXPERIMENTAL
Intervention: Inertial load
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Spring load
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Stretched-spring load
Number of subjects: 10
Study: 6143471

Group type: EXPERIMENTAL
Intervention: Diuretic (hydrochlorothiazide)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Beta-adrenoceptor blocker (metoprolol)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Spironolactone (in 6 patients)
Number of subjects: 47
Study: 30156171

Group type: EXPERIMENTAL
Intervention: Pharmacist PPRA group
Number of subjects: 610

Group type: COMPARATOR
Intervention: Fellow PPRA group
Number of subjects: 610
Study: 26797117

Group type: EXPERIMENTAL
Intervention: Telephone-delivered problem-solving training (PST)
Number of subjects: 80
Study: 23535984

Group type: EXPERIMENTAL
Intervention: Nurse-led intensive care follow-up programme
Number of subjects: 286

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 286
Study: 22906847

Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 20

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 20
Study: 20739445

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplement containing (n-3) fatty acids (2.0 g EPA + 0.9 g DHA/d)
Number of subjects: 40
Study: 18631272

Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 542

Group type: COMPARATOR
Intervention: CRT-P
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Beta-blocker treatment
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: CRT-D device
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Chronic renal failure
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: History of atrial fibrillation
Number of subjects: 542
Study: 15705052

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20 g.d(‐1) x 5 d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucose placebo (PL)
Number of subjects: 0
Study: 12885709

Group type: EXPERIMENTAL
Intervention: Low-phytate bread fortified with zinc sulfate (60 mg elemental Zn/kg wheat flour)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Higher-phytate porridge fortified with zinc sulfate (60 mg elemental Zn/kg wheat flour)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Higher-phytate porridge fortified with zinc oxide (60 mg elemental Zn/kg wheat flour)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Higher-phytate porridge with additional test meal fortified with zinc oxide and labeled with (65)ZnCl(2)
Number of subjects: 22
Study: 10673885

Group type: EXPERIMENTAL
Intervention: Oxygen 3 litre min‐1 before sevoflurane
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Oxygen 6 litre min‐1 before sevoflurane
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Non-rebreathing group (sevoflurane in oxygen 6 litre min‐1 from the start)
Number of subjects: 28
Study: 8671370

Group type: EXPERIMENTAL
Intervention: Low sodium group
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal sodium group
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 18
Study: 1816218

Group type: EXPERIMENTAL
Intervention: Acetate dialysis
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bicarbonate dialysis
Number of subjects: 30
Study: 6356145

Group type: EXPERIMENTAL
Intervention: Mixed-beam irradiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutrons-only therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutron or mixed-beam therapy
Number of subjects: 0
Study: 29125915

Group type: EXPERIMENTAL
Intervention: Beetroot juice taken before and after exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no beetroot juice)
Number of subjects: 0
Study: 26946121

Group type: EXPERIMENTAL
Intervention: HealthLinks intervention
Number of subjects: 3302

Group type: EXPERIMENTAL
Intervention: HealthLinks plus wellness committees
Number of subjects: 3302

Group type: COMPARATOR
Intervention: Delayed control group
Number of subjects: 3302
Study: 25552615

Group type: EXPERIMENTAL
Intervention: Aerobic exercise programme (12-week duration, regular follow-up visits to a specialised physiotherapist)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Aerobic exercise programme
Number of subjects: 120
Study: 22731794

Group type: EXPERIMENTAL
Intervention: Intensive therapy group (higher frequency of follow-up)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Conventional therapy group (lower frequency of follow-up)
Number of subjects: 155
Study: 19962986

Group type: EXPERIMENTAL
Intervention: Earlier-onset puberty (serum testosterone levels >= 2.5 ng/mL at 15 years old, n = 87)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Valine allele carrier at the SRD5A2 V89L polymorphism
Number of subjects: 100
Study: 18396081

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection with EMG assistance
Number of subjects: 23

Group type: COMPARATOR
Intervention: Botulinum toxin injection without EMG assistance
Number of subjects: 23
Study: 17121034

Group type: EXPERIMENTAL
Intervention: Chinese medicine (CM) group with basic therapy and syndrome-differentiation dependent TCM treatment
Number of subjects: 397

Group type: COMPARATOR
Intervention: Western medicine (WM) group treated with non-steroidal anti-inflammatory drugs and slow-acting antirheumatic drug
Number of subjects: 397
Study: 13679479

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors (ACEIs)
Number of subjects: 1860
Study: 10693638

Group type: EXPERIMENTAL
Intervention: CsA
Number of subjects: 30

Group type: COMPARATOR
Intervention: MMF or AZA
Number of subjects: 30
Study: 9349927

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 1.625 mg/day via pMDI
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide 1.60 mg/day via pMDI with integrated spacer
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo pMDI
Number of subjects: 12
Study: 8394847

Group type: EXPERIMENTAL
Intervention: ACTH4‐9 fragment ebiratide (60, 300, and 600 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 3031976

Group type: EXPERIMENTAL
Intervention: VAC-LE
Number of subjects: 45

Group type: COMPARATOR
Intervention: VAC
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: VAC-LE (CNS positive patients)
Number of subjects: 45
Study: 31128916

Group type: EXPERIMENTAL
Intervention: LPS + NGAL
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NGAL-RNAi + LPS + NGAL
Number of subjects: 0

Group type: COMPARATOR
Intervention: NGAL-RNAi + LPS
Number of subjects: 0

Group type: COMPARATOR
Intervention: LPS
Number of subjects: 0
Study: 26766637

Group type: EXPERIMENTAL
Intervention: 0.75% povidone iodine solution for at least 3 minutes
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Mucosal disinfectant (group A)
Number of subjects: 184

Group type: COMPARATOR
Intervention: No intervention (group B)
Number of subjects: 184
Study: 25219351

Group type: EXPERIMENTAL
Intervention: Metformin 500 mg BID for 3 days followed by topiramate 100 mg BID from days 4 to 10
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg QD for 8 days followed by topiramate 96 mg BID from days 9 to 22
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topiramate 96 mg BID alone for 11 days followed by pioglitazone 30 mg QD and topiramate 96 mg BID from days 12 to 22
Number of subjects: 0
Study: 22366878

Group type: EXPERIMENTAL
Intervention: Progressive resistance training (80% of maximum) twice weekly for 10 weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual daily activities (Control group)
Number of subjects: 18
Study: 19966592

Group type: EXPERIMENTAL
Intervention: Morning‐Trained Group (MTG, 7:00‐9:00 hr)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Evening‐Trained Group (ETG, 17:00‐19:00 hr)
Number of subjects: 16
Study: 18019884

Group type: EXPERIMENTAL
Intervention: Walking intervention (structured and supervised walking program meeting three times per week for 1 hour)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Yoga intervention (supervised yoga program meeting twice per week for 90 minutes)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 164
Study: 15841103

Group type: EXPERIMENTAL
Intervention: Testosterone replacement during leuprolide acetate treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Induced hypogonadal condition (leuprolide plus placebo)
Number of subjects: 10
Study: 11864781

Group type: EXPERIMENTAL
Intervention: Antioxidant vitamins A, C, and E
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10495461

Group type: EXPERIMENTAL
Intervention: Bootstrap resampling method for bias correction in group sequential designs
Number of subjects: 0
Study: 7743791

Group type: EXPERIMENTAL
Intervention: Normal values of cardiac index (CI) 2.5 < or = CI < or = 3.5 L min‐1 m‐2
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Supranormal values of cardiac index (CI > or = 4.5 L min‐1 m‐2)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Mixed venous oxygen saturation (SvO2) > or = 70% or (Sat a‐‐Sat v) < or = 20%
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Conventional Swan‐Ganz catheter with scheduled samples of mixed venous O2 saturation
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Optical catheter with continuous SvO2 evaluation
Number of subjects: 98
Study: 2035820

Group type: EXPERIMENTAL
Intervention: Propofol-fentanyl
Number of subjects: 20

Group type: COMPARATOR
Intervention: Etomidate-midazolam-fentanyl
Number of subjects: 20
Study: 6119875

Group type: COMPARATOR
Intervention: Propranolol, Atenolol
Number of subjects: 861

Group type: COMPARATOR
Intervention: Oxprenolol, Disopyramide phosphate
Number of subjects: 861

Group type: EXPERIMENTAL
Intervention: Disopyramide phosphate
Number of subjects: 861
Study: 31423921

Group type: EXPERIMENTAL
Intervention: Epoetin beta 50 IU/kg per week for 50 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no epoetin beta)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Epoetin beta
Number of subjects: 56
Study: 27886020

Group type: EXPERIMENTAL
Intervention: Active CES
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham CES
Number of subjects: 50
Study: 25248845

Group type: EXPERIMENTAL
Intervention: Homologous muscles (triceps muscles of the left and right limbs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-homologous muscles (biceps left limb and triceps right limb)
Number of subjects: 0
Study: 24211698

Group type: EXPERIMENTAL
Intervention: Total body resistance exercise (TOTRX)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Lumbar extensor exercise (LEXT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 49
Study: 22312038

Group type: EXPERIMENTAL
Intervention: Triventricular (TriV) pacing
Number of subjects: 43
Study: 19998456

Group type: EXPERIMENTAL
Intervention: Forced expression of CD24 in HCT116 cells
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Knockdown of CD24 in HT29 cells
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (normal tissue)
Number of subjects: 10
Study: 17561792

Group type: EXPERIMENTAL
Intervention: Insulin aspart
Number of subjects: 57

Group type: COMPARATOR
Intervention: Human regular insulin (Control)
Number of subjects: 57
Study: 15708175

Group type: EXPERIMENTAL
Intervention: Regular coffee (80 mg of caffeine)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Decaffeinated coffee
Number of subjects: 16
Study: 11998992

Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once-daily
Number of subjects: 31

Group type: COMPARATOR
Intervention: Ipratropium 40 microg four-times daily
Number of subjects: 31
Study: 10551290

Group type: EXPERIMENTAL
Intervention: 2 mg of dexamethasone sodium phosphate
Number of subjects: 19

Group type: COMPARATOR
Intervention: 20 mg of triamcinolone acetonide
Number of subjects: 19
Study: 8703660

Group type: EXPERIMENTAL
Intervention: Azapropazone 300 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Azapropazone 600 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Azapropazone 1200 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Azapropazone
Number of subjects: 20
Study: 6809960

Group type: EXPERIMENTAL
Intervention: bacillus Calmette-Guerin
Number of subjects: 49

Group type: COMPARATOR
Intervention: thio-tepa
Number of subjects: 49
Study: 28064148

Group type: EXPERIMENTAL
Intervention: Weight Loss (WL)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Weight Loss + Aerobic Training (WL + AT)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Weight Loss + Resistance Training (WL + RT)
Number of subjects: 249
Study: 26394065

Group type: EXPERIMENTAL
Intervention: Anaplasma strains genetically related to A. phagocytophilum
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: A. ovis prevalence in adults (≥2 years)
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: A. ovis prevalence in ewes vs rams
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: A. ovis infection rate in local breed goats
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: A. ovis infection rate in tick-infested goats
Number of subjects: 563
Study: 24297687

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 2737

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2737
Study: 21953849

Group type: EXPERIMENTAL
Intervention: Ultrasound evaluation of median nerve deformation during finger motions
Number of subjects: 58
Study: 19445434

Group type: EXPERIMENTAL
Intervention: BSE intervention program
Number of subjects: 616

Group type: COMPARATOR
Intervention: Dietary intervention (control group)
Number of subjects: 616
Study: 21102210

Group type: EXPERIMENTAL
Intervention: Local anesthetic continuous infusion device (pain pump) in addition to oral analgesics
Number of subjects: 54

Group type: COMPARATOR
Intervention: Oral analgesics only
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Local anesthetic continuous infusion device (pain pump)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 54
Study: 15949082

Group type: EXPERIMENTAL
Intervention: Bupivacaine-soaked Merocel pack
Number of subjects: 57

Group type: COMPARATOR
Intervention: Saline-soaked Merocel pack
Number of subjects: 57
Study: 12139207

Group type: EXPERIMENTAL
Intervention: Lormetazepam 1 mg tablet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15321223

Group type: EXPERIMENTAL
Intervention: 2% lidocaine-epinephrine
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.5% bupivacaine
Number of subjects: 20
Study: 8187029

Group type: EXPERIMENTAL
Intervention: 443c81 (5 ml of a 4 mg/ml solution nebulized) four times daily for 7 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 443c81 (5 ml of a 4 mg/ml solution nebulized)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 3251339

Group type: EXPERIMENTAL
Intervention: Single intravenous and oral doses of 50 mg of UDCA
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Single oral doses of 25, 100, and 300 mg of UDCA
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: UDCA clearance in normal subjects
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Enterohepatic circulation of UDCA
Number of subjects: 10
Study: 12742480

Group type: EXPERIMENTAL
Intervention: Reduced tacrolimus (rTAC) with sirolimus (SRL)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard tacrolimus (sTAC) with sirolimus (SRL)
Number of subjects: 64
Study: 31153789

Group type: EXPERIMENTAL
Intervention: Pilates group 1 (once a week)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Pilates group 2 (twice a week)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Pilates group 3 (three times a week)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: All Pilates groups (1, 2, and 3)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 222
Study: 27804067

Group type: EXPERIMENTAL
Intervention: Constant-Activity-Rate (CA) infusion
Number of subjects: 22

Group type: COMPARATOR
Intervention: Constant-Flow-Rate (CF) infusion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22
Study: 27281806

Group type: EXPERIMENTAL
Intervention: Weekly iron and folic acid (IFA) supplements (60 mg Fe and 2800 μg FA)
Number of subjects: 5011

Group type: EXPERIMENTAL
Intervention: Weekly multiple micronutrient (MM) supplements (same amount of FA and iron plus other MMs)
Number of subjects: 5011

Group type: COMPARATOR
Intervention: Folic acid (FA) supplements (2800 μg FA)
Number of subjects: 5011
Study: 24933584

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation in the beginning of life
Number of subjects: 10
Study: 22868283

Group type: EXPERIMENTAL
Intervention: Tube B (MINI One gastrostomy tube)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Tube A (MIC-Key gastrostomy tube)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both tube types
Number of subjects: 21
Study: 20443499

Group type: EXPERIMENTAL
Intervention: Hybrid dosimetric constraints
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: RT01-based dose-volume constraints
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CHHiP dose-volume constraints
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dose-volume constraints proposed by other researchers
Number of subjects: 0
Study: 18560820

Group type: EXPERIMENTAL
Intervention: Lime powder solution (Group 1)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Potassium citrate (Group 2)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Lactose as placebo (Group 3)
Number of subjects: 31
Study: 15986401

Group type: EXPERIMENTAL
Intervention: Nurse-driven cancer care intervention, monthly meetings for 6 months with an oncology nurse, using an interactive computer program.
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard care (control group).
Number of subjects: 99
Study: 12566634

Group type: EXPERIMENTAL
Intervention: DIAGNOdent
Number of subjects: 109

Group type: COMPARATOR
Intervention: Radiographic examination
Number of subjects: 109